ScholarIQanswers from OpenAlex & ORCID
Stefan Fröhling
ResearcherPublications, citations & collaboration network
Stefan Fröhling is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Stefan Fröhling have?
ScholarIQindexed works
Stefan Fröhling has 623 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Stefan Fröhling have?
ScholarIQcitation count
Stefan Fröhling has 33,103 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Stefan Fröhling?
ScholarIQh-index
Stefan Fröhling has an h-index of 80 in OpenAlex.
What is the i10-index of Stefan Fröhling?
ScholarIQi10-index
Stefan Fröhling has an i10-index of 231 in OpenAlex.
What is the ORCID of Stefan Fröhling?
ScholarIQorcid
The ORCID for Stefan Fröhling is on the source record.
What is the OpenAlex record for Stefan Fröhling?
ScholarIQopenalex
The OpenAlex for Stefan Fröhling is on the source record.
What are the most-cited papers on Stefan Fröhling?
ScholarIQmost cited works
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie, Pablo Tamayo, Jesse S. Boehm, So Young Kim, Susan E. Moody, Ian F. Dunn, Anna C. Schinzel, Péter Sandy, Etienne Meylan, Claudia Scholl, Stefan Fröhling, Edmond M. Chan, Martin L. Sos, Kathrin Michel, Craig H. Mermel, Serena J. Silver, Barbara A. Weir, Jan H. Reiling, Qing Sheng, Piyush B. Gupta, Raymond Wadlow, Hanh Le, Sebastian Hoersch, Ben S. Wittner, Sridhar Ramaswamy, David M. Livingston, David M. Sabatini, Matthew Meyerson, Roman K. Thomas, Eric S. Lander, Jill P. Mesirov, David E. Root, D. Gary Gilliland, Tyler Jacks, William C. Hahn
Accurate and efficient detection of gene fusions from RNA sequencing data
Sebastian Uhrig, Julia Ellermann, Tatjana Walther, Pauline Burkhardt, Martina Fröhlich, Barbara Hutter, Umut H. Toprak, Olaf Neumann, Albrecht Stenzinger, Claudia Scholl, Stefan Fröhling, Benedikt Brors
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
Michael G. Kharas, Christopher J. Lengner, Fátima Al‐Shahrour, Lars Bullinger, Brian Ball, Samir Zaidi, Kelly Morgan, Winnie F. Tam, Mahnaz Paktinat, Rachel Okabe, Maricel Gozo, William S. Einhorn, Steven Lane, Claudia Scholl, Stefan Fröhling, Mark D. Fleming, Benjamin L. Ebert, D. Gary Gilliland, Rudolf Jaenisch, George Q. Daley
AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias
Stephen M. Sykes, Steven Lane, Lars Bullinger, Demetrios Kalaitzidis, Rushdia Z. Yusuf, Borja Sáez, Francesca Ferraro, François Mercier, Harshabad Singh, Kristina Brumme, Sanket S. Acharya, Claudia Scholl, Zuzana Tóthová, Eyal C. Attar, Stefan Fröhling, Ronald A. DePinho, D. Gary Gilliland, Scott A. Armstrong, David T. Scadden
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
Michael Allgäuer, Jan Budczies, Petros Christopoulos, Volker Endris, Amelie Lier, Eugen Rempel, Anna‐Lena Volckmar, Martina Kirchner, Moritz von Winterfeld, Jonas Leichsenring, Olaf Neumann, Stefan Fröhling, Roland Penzel, Michael Thomas, Peter Schirmacher, Albrecht Stenzinger